Literature DB >> 23280632

Intentions for bilateral mastectomy among newly diagnosed breast cancer patients.

Lesley King1, Suzanne C O'Neill, Elizabeth Spellman, Beth N Peshkin, Heiddis Valdimarsdottir, Shawna Willey, Kara Grace Leventhal, Tiffani DeMarco, Rachel Nusbaum, Elizabeth Feldman, Lina Jandorf, Marc D Schwartz.   

Abstract

BACKGROUND: Recent trends suggest that bilateral mastectomy (BM) is on the rise among women diagnosed with unilateral breast cancer. Few studies have investigated the factors associated with the decision to have more aggressive surgery among young, high risk patients.
METHODS: As part of a larger study, 284 women aged 50 and under completed an initial survey within 6 weeks of a breast cancer diagnosis. We assessed sociodemographics, medical and family history variables, treatment recommendations, preferences and concerns, distress, perceived risk, knowledge, and neuroticism. We used multiple regression with backward entry to assess the relationship between these variables and our outcomes of decisional conflict and intentions for BM.
RESULTS: Higher decisional conflict was associated with being less educated, unmarried, more anxious and less likely to have received a surgical recommendation. Preference for BM was associated with higher neuroticism, perceived risk for contralateral breast cancer, pre-testing risk of carrying a BRCA1/2 mutation, having received either a surgical recommendation (vs. no recommendation), and lower preference for lumpectomy.
CONCLUSIONS: For younger women, a surgical recommendation is associated with lower decisional conflict and stronger intention for BM. Results highlight the importance of effective risk communication and decision support between a woman and her surgeon.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23280632      PMCID: PMC3687585          DOI: 10.1002/jso.23307

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  35 in total

1.  Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.

Authors:  Marlene H Frost; Jeffrey M Slezak; Nho V Tran; Constance I Williams; Joanne L Johnson; John E Woods; Paul M Petty; John H Donohue; Clive S Grant; Jeff A Sloan; Thomas A Sellers; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2005-10-03       Impact factor: 44.544

2.  Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.

Authors:  Lisa J Herrinton; William E Barlow; Onchee Yu; Ann M Geiger; Joann G Elmore; Mary B Barton; Emily L Harris; Sharon Rolnick; Roy Pardee; Gail Husson; Ana Macedo; Suzanne W Fletcher
Journal:  J Clin Oncol       Date:  2005-03-28       Impact factor: 44.544

3.  Validation of a decisional conflict scale.

Authors:  A M O'Connor
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

4.  The Brief Symptom Inventory: an introductory report.

Authors:  L R Derogatis; N Melisaratos
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

5.  Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

Authors:  D Schrag; K M Kuntz; J E Garber; J C Weeks
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

6.  Breast cancer patients' personality style, age, and treatment decision making.

Authors:  J D Johnson; C S Roberts; C E Cox; D S Reintgen; J S Levine; M Parsons
Journal:  J Surg Oncol       Date:  1996-11       Impact factor: 3.454

7.  Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age.

Authors:  Carla S Fisher; Tonya Martin-Dunlap; Megan Baker Ruppel; Feng Gao; Jordan Atkins; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2012-07-26       Impact factor: 5.344

8.  Impact of Event Scale: a measure of subjective stress.

Authors:  M Horowitz; N Wilner; W Alvarez
Journal:  Psychosom Med       Date:  1979-05       Impact factor: 4.312

9.  Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.

Authors:  Marc D Schwartz; Caryn Lerman; Barbara Brogan; Beth N Peshkin; Chanita Hughes Halbert; Tiffani DeMarco; William Lawrence; David Main; Clinton Finch; Colette Magnant; Marie Pennanen; Theodore Tsangaris; Shawna Willey; Claudine Isaacs
Journal:  J Clin Oncol       Date:  2004-04-05       Impact factor: 50.717

10.  Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.

Authors:  R Rawal; J Lorenzo Bermejo; K Hemminki
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

View more
  7 in total

1.  Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Authors:  Mary Kathleen Ladd; Beth N Peshkin; Leigha Senter; Shari Baldinger; Claudine Isaacs; Hannah Segal; Samantha Philip; Chloe Phillips; Kate Shane; Aimee Martin; Veronique Weinstein; Robert Pilarski; Joanne Jeter; Kevin Sweet; Bonnie Hatten; Elisabeth J Wurtmann; Shanda Phippen; Della Bro; Marc D Schwartz
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

2.  Predictors of genetic testing uptake in newly diagnosed breast cancer patients.

Authors:  Mary K Ladd; Beth N Peshkin; Claudine Isaacs; Gillian Hooker; Shawna Willey; Heiddis Valdimarsdottir; Tiffani DeMarco; Suzanne O'Neill; Savannah Binion; Marc D Schwartz
Journal:  J Surg Oncol       Date:  2020-04-28       Impact factor: 3.454

3.  Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.

Authors:  Mara Tynan; Beth N Peshkin; Claudine Isaacs; Shawna Willey; Heiddis B Valdimarsdottir; Rachel Nusbaum; Gillian Hooker; Suzanne C O'Neill; Lina Jandorf; Scott P Kelly; Jessica Heinzmann; Sarah Kelleher; Elizabeth Poggi; Marc D Schwartz
Journal:  Breast Cancer Res Treat       Date:  2020-01-01       Impact factor: 4.872

4.  Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.

Authors:  Angie Tong; Scott Kelly; Rachel Nusbaum; Kristi Graves; Beth N Peshkin; Heiddis B Valdimarsdottir; Marie Wood; Wendy McKinnon; Judy Garber; Shelley R McCormick; Lina Jandorf; Marc D Schwartz
Journal:  Psychooncology       Date:  2014-05-17       Impact factor: 3.894

5.  Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model.

Authors:  Sharon Manne; Deborah Kashy; Terrance Albrecht; Yu-Ning Wong; Anne Lederman Flamm; Al B Benson; Suzanne M Miller; Linda Fleisher; Joanne Buzaglo; Nancy Roach; Michael Katz; Eric Ross; Michael Collins; David Poole; Stephanie Raivitch; Dawn M Miller; Tyler G Kinzy; Tasnuva Liu; Neal J Meropol
Journal:  Med Decis Making       Date:  2013-11-18       Impact factor: 2.583

6.  Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.

Authors:  Reshma Jagsi; Sarah T Hawley; Kent A Griffith; Nancy K Janz; Allison W Kurian; Kevin C Ward; Ann S Hamilton; Monica Morrow; Steven J Katz
Journal:  JAMA Surg       Date:  2017-03-01       Impact factor: 16.681

7.  Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries.

Authors:  Felix G Rebitschek; Nora Pashayan; Martin Widschwendter; Odette Wegwarth
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.